UK to thwart EU vax threats by making more jabs at home

Business Secretary Kwasi Kwarteng has reportedly held talks with Vaccines Minister Nadhim Zahawi about plans to ramp up domestic production of coronavirus vaccines, amid repeated EU threats to block exports of the life-saving medicines.

A government source appeared to confirm to the Telegraph that plans are indeed underway to increase UK production, saying: “There is a lot of domestic production already. We are always looking at ways we can increase vaccine production in the UK. The Government is looking at ways vaccine supplies can be increased all the time.”

UK based plants in Oxford and Keele are already producing a significant number of doses here in the UK, providing the powerhouse backbone of Britain’s Europe-beating vaccine roll-out.

Bulk manufacturing of the as yet unapproved Valneva vaccine started in Scotland back in January, highlighting the foresight of British government jab boffins to shore up supply even before the flailing EU’s latest round of pathetic threats.

According to the latest comparable statistics from Our World in Data, the EU had delivered just 12.43 doses of the drug per 100 people compared to a whopping 41.65 doled out by British healthcare heroes.

And the government today confirmed that half of all British adults had received their first dose of the drug, following a record-breaking day that saw 711,156 jabs administered across the UK.

But the monumental success of Britain’s vaccine roll-out has caused shameful envy on the continent, where a botched procurement scheme hatched by incompetent Eurocrats has left EU member-states lacking doses.

European Commission boss Ursula von der Leyen earlier this week warned that “all options are on the table” in her bid to unpick the mess made by her own bungling bureaucracy.

That includes use of extreme emergency measures under Article 122, which could see Eurocrats seize factories, suspend intellectual property rights, and ban the export of doses.

She upped the ante again today by warning AstraZeneca directly that they could indeed face an export ban, making British self-sufficiency all the more important.